WANG Xian-ming, TANG Jing. The Safety and Therapeutic Effect Evaluation of Pembrolizumab in Patients with Advanced PD-L1 Positive Triple Negative Breast Cancer[J]. Journal of Evidence-Based Medicine, 2017, 17(3): 146-149. DOI: 10.12019/j.issn.1671-5144.2017.03.007
|
Citation:
|
WANG Xian-ming, TANG Jing. The Safety and Therapeutic Effect Evaluation of Pembrolizumab in Patients with Advanced PD-L1 Positive Triple Negative Breast Cancer[J]. Journal of Evidence-Based Medicine, 2017, 17(3): 146-149. DOI: 10.12019/j.issn.1671-5144.2017.03.007
|
WANG Xian-ming, TANG Jing. The Safety and Therapeutic Effect Evaluation of Pembrolizumab in Patients with Advanced PD-L1 Positive Triple Negative Breast Cancer[J]. Journal of Evidence-Based Medicine, 2017, 17(3): 146-149. DOI: 10.12019/j.issn.1671-5144.2017.03.007
|
Citation:
|
WANG Xian-ming, TANG Jing. The Safety and Therapeutic Effect Evaluation of Pembrolizumab in Patients with Advanced PD-L1 Positive Triple Negative Breast Cancer[J]. Journal of Evidence-Based Medicine, 2017, 17(3): 146-149. DOI: 10.12019/j.issn.1671-5144.2017.03.007
|
DownLoad: